Health Funds Ink $5.5M Generic Drugs Deal With Breckenridge
A proposed class of end-payers who allegedly overpaid for generic drugs have asked a federal court for preliminary approval of a $5.5 million settlement with Breckenridge Pharmaceutical Inc., though notifying class...To view the full article, register now.
Already a subscriber? Click here to view full article